News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services ...
Speaking at Semafor's World Economy Summit, Marty Makary diverged from Robert F. Kennedy Jr.’s stance on vaccine ...
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
3dOpinion
MedPage Today on MSNInside the FDA: Low Morale and Uncertainty Plague StaffSeveral current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...
Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
In an exclusive interview with physician and writer Dr. Jeremy Faust on Substack, Makary opened up about his first weeks on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results